Literature DB >> 7690276

Pharmacology and physiology of colloids.

J B Salmon1, M G Mythen.   

Abstract

The importance of an adequate circulating volume in the critically ill is well established. Plasma, albumin, synthetic colloids and crystalloids may all be used for volume expansion but the first two are expensive and crystalloids have to be given in much larger volumes than colloids to achieve the same effect. Synthetic colloids provide a cheaper, safe, effective alternative. There are three classes of synthetic colloid; dextrans, gelatins and hydroxyethyl starches; each is available in several formulations with different properties which affect their initial plasma expanding effects, retention in the circulation and side-effects. There is no ideal colloid but those with low molecular weights such as gelatins are more suitable for rapid, short term volume expansion whilst in states of capillary leak where longer term effects are required hydroxyethyl starches are more effective. Dextrans are as effective as the alternatives but produce more side-effects and the need to pre-treat with hapten-dextran renders them unwieldy in use. Albumin is as persistent as hydroxyethyl starch in the healthy circulation but is retained less well in states of capillary leak. It has no significant advantages over starches and is much more expensive.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690276     DOI: 10.1016/s0268-960x(05)80021-9

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  9 in total

1.  Albumin: saint or sinner?

Authors:  S Nadel; C De Munter; J Britto; M Levin; P Habib
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 2.  In neonates requiring intravascular volume resuscitation is the use of gelofusine safe and efficacious?

Authors:  Minesh Khashu; Velur Balasubramaniam
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

Review 3.  Colloid volume expanders. Problems, pitfalls and possibilities.

Authors:  J S Roberts; S L Bratton
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

4.  Fluid resuscitation with colloid or crystalloid solutions. Comparing different studies is difficult.

Authors:  J Watts
Journal:  BMJ       Date:  1998-07-25

Review 5.  Exploding the albumin myth.

Authors:  M M Tjoeng; A K Bartelink; L G Thijs
Journal:  Pharm World Sci       Date:  1999-02

6.  Redefining the properties of an osmotic agent in an intestinal-specific preservation solution.

Authors:  Kimberly Schlachter; Matthew S Kokotilo; Jodi Carter; Aducio Thiesen; Angela Ochs; Rachel G Khadaroo; Thomas A Churchill
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

7.  Plasma expanders stabilize human microvessels in microfluidic scaffolds.

Authors:  Alexander D Leung; Keith H K Wong; Joe Tien
Journal:  J Biomed Mater Res A       Date:  2012-04-04       Impact factor: 4.396

8.  Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial.

Authors:  Samuel Akech; Samson Gwer; Richard Idro; Greg Fegan; Alice C Eziefula; Charles R J C Newton; Michael Levin; Kathryn Maitland
Journal:  PLoS Clin Trials       Date:  2006-09-15

9.  Cardiovascular, colloid osmotic pressure, and hemostatic effects of 2 formulations of hydroxyethyl starch in healthy horses.

Authors:  K L Epstein; A Bergren; S Giguère; B M Brainard
Journal:  J Vet Intern Med       Date:  2013-11-13       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.